Incitec Pivot Past Earnings Performance
Past criteria checks 0/6
Incitec Pivot's earnings have been declining at an average annual rate of -15.7%, while the Chemicals industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 8.3% per year.
Key information
-15.7%
Earnings growth rate
-17.5%
EPS growth rate
| Chemicals Industry Growth | 12.4% |
| Revenue growth rate | 8.3% |
| Return on equity | -9.9% |
| Net Margin | -8.9% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Incitec Pivot makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 5,343 | -478 | 1,341 | 0 |
| 30 Jun 24 | 5,283 | -310 | 1,317 | 0 |
| 31 Mar 24 | 5,224 | -142 | 1,294 | 0 |
| 31 Dec 23 | 5,334 | 67 | 1,275 | 0 |
| 30 Sep 23 | 5,444 | 277 | 1,256 | 0 |
| 31 Mar 23 | 5,953 | 488 | 1,218 | 0 |
| 31 Dec 22 | 5,755 | 569 | 1,162 | 0 |
| 30 Sep 22 | 5,556 | 649 | 1,107 | 0 |
| 30 Jun 22 | 5,504 | 660 | 1,087 | 0 |
| 31 Mar 22 | 4,875 | 402 | 1,051 | 0 |
| 31 Dec 21 | 4,627 | 276 | 1,034 | 0 |
| 30 Sep 21 | 4,380 | 149 | 1,016 | 0 |
| 30 Jun 21 | 4,115 | 122 | 1,005 | 0 |
| 31 Mar 21 | 3,849 | 95 | 995 | 0 |
| 31 Dec 20 | 3,915 | 109 | 1,017 | 0 |
| 30 Sep 20 | 3,980 | 123 | 1,040 | 0 |
| 30 Jun 20 | 4,026 | 149 | 1,049 | 0 |
| 31 Mar 20 | 4,072 | 175 | 1,059 | 0 |
| 31 Dec 19 | 4,016 | 164 | 1,046 | 0 |
| 30 Sep 19 | 3,960 | 152 | 1,033 | 0 |
| 30 Jun 19 | 3,955 | 197 | 1,021 | 0 |
| 31 Mar 19 | 3,951 | 242 | 1,009 | 0 |
| 31 Dec 18 | 3,922 | 225 | 1,001 | 0 |
| 30 Sep 18 | 3,892 | 208 | 993 | 0 |
| 30 Jun 18 | 3,772 | 191 | 973 | 0 |
| 31 Mar 18 | 3,651 | 174 | 952 | 0 |
| 31 Dec 17 | 3,574 | 246 | 939 | 0 |
| 30 Sep 17 | 3,497 | 319 | 926 | 0 |
| 30 Jun 17 | 3,442 | 284 | 926 | 0 |
| 31 Mar 17 | 3,388 | 249 | 926 | 0 |
| 31 Dec 16 | 3,383 | 188 | 932 | 0 |
| 30 Sep 16 | 3,378 | 128 | 939 | 0 |
| 30 Jun 16 | 3,493 | 206 | 941 | 0 |
| 31 Mar 16 | 3,609 | 284 | 943 | 0 |
| 31 Dec 15 | 3,645 | 341 | 951 | 0 |
| 30 Sep 15 | 3,682 | 399 | 958 | 0 |
| 30 Jun 15 | 3,573 | 338 | 938 | 0 |
| 31 Mar 15 | 3,465 | 278 | 918 | 0 |
| 31 Dec 14 | 3,421 | 262 | 902 | 0 |
| 30 Sep 14 | 3,378 | 247 | 886 | 0 |
| 30 Jun 14 | 3,445 | 311 | 887 | 0 |
| 31 Mar 14 | 3,512 | 375 | 887 | 0 |
| 31 Dec 13 | 3,471 | 371 | 883 | 0 |
Quality Earnings: I5P is currently unprofitable.
Growing Profit Margin: I5P is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: I5P is unprofitable, and losses have increased over the past 5 years at a rate of 15.7% per year.
Accelerating Growth: Unable to compare I5P's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: I5P is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (5%).
Return on Equity
High ROE: I5P has a negative Return on Equity (-9.88%), as it is currently unprofitable.